"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma.
Med Princ Pract
; 27(3): 260-266, 2018.
Article
in En
| MEDLINE
| ID: mdl-29414831
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Asthma
/
Anti-Asthmatic Agents
/
Omalizumab
Type of study:
Observational_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Med Princ Pract
Journal subject:
EDUCACAO
Year:
2018
Document type:
Article
Affiliation country:
Kuwait
Country of publication:
Switzerland